603456 Stock Overview
Manufactures and sells active pharmaceutical ingredients (API) and intermediates in China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Zhejiang Jiuzhou Pharmaceutical Co., Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥15.67 |
| 52 Week High | CN¥28.16 |
| 52 Week Low | CN¥11.83 |
| Beta | 0.23 |
| 11 Month Change | 2.42% |
| 3 Month Change | 31.02% |
| 1 Year Change | -42.64% |
| 33 Year Change | -72.69% |
| 5 Year Change | 20.91% |
| Change since IPO | 153.88% |
Recent News & Updates
Zhejiang Jiuzhou Pharmaceutical Co., Ltd's (SHSE:603456) Shares Leap 25% Yet They're Still Not Telling The Full Story
Oct 01
Zhejiang Jiuzhou Pharmaceutical (SHSE:603456) Seems To Use Debt Quite Sensibly
Sep 25Recent updates
Zhejiang Jiuzhou Pharmaceutical Co., Ltd's (SHSE:603456) Shares Leap 25% Yet They're Still Not Telling The Full Story
Oct 01Zhejiang Jiuzhou Pharmaceutical (SHSE:603456) Seems To Use Debt Quite Sensibly
Sep 25Here's Why Zhejiang Jiuzhou Pharmaceutical (SHSE:603456) Can Manage Its Debt Responsibly
Jun 13Zhejiang Jiuzhou Pharmaceutical Co., Ltd's (SHSE:603456) Business And Shares Still Trailing The Market
May 24Zhejiang Jiuzhou Pharmaceutical's (SHSE:603456) Solid Earnings May Rest On Weak Foundations
May 01Zhejiang Jiuzhou Pharmaceutical Co., Ltd Just Missed Revenue By 17%: Here's What Analysts Think Will Happen Next
Apr 11Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHSE:603456) Shares Could Be 32% Above Their Intrinsic Value Estimate
Feb 28Shareholder Returns
| 603456 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 0.4% | -1.3% | -3.4% |
| 1Y | -42.6% | -3.4% | 6.1% |
Return vs Industry: 603456 underperformed the CN Pharmaceuticals industry which returned -3.4% over the past year.
Return vs Market: 603456 underperformed the CN Market which returned 6.1% over the past year.
Price Volatility
| 603456 volatility | |
|---|---|
| 603456 Average Weekly Movement | 7.3% |
| Pharmaceuticals Industry Average Movement | 7.2% |
| Market Average Movement | 8.2% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.5% |
Stable Share Price: 603456 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 603456's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1973 | 4,877 | Yi Jiang Mei | www.jiuzhoupharma.com |
Zhejiang Jiuzhou Pharmaceutical Co., Ltd manufactures and sells active pharmaceutical ingredients (API) and intermediates in China and internationally. Its API pipeline comprise central nervous system, non-steroidal, anti-infection, hypoglycemic and antiviral, tumor treatment, anti-depressant, Parkinson, HCV drugs, diabetes, cardiovascular, and respiratory anti-infection drugs. The company also provides asymmetric catalysts and lithium battery materials.
Zhejiang Jiuzhou Pharmaceutical Co., Ltd Fundamentals Summary
| 603456 fundamental statistics | |
|---|---|
| Market cap | CN¥14.09b |
| Earnings (TTM) | CN¥697.36m |
| Revenue (TTM) | CN¥4.91b |
20.2x
P/E Ratio2.9x
P/S RatioIs 603456 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603456 income statement (TTM) | |
|---|---|
| Revenue | CN¥4.91b |
| Cost of Revenue | CN¥3.33b |
| Gross Profit | CN¥1.58b |
| Other Expenses | CN¥880.59m |
| Earnings | CN¥697.36m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.78 |
| Gross Margin | 32.12% |
| Net Profit Margin | 14.20% |
| Debt/Equity Ratio | 5.7% |
How did 603456 perform over the long term?
See historical performance and comparison